💹 Your Post-Notable Earnings Report (Oct 17)

✅ Make this one trade by 2:59 PM on Friday (You will thank me on Monday morning) 💰 (ad)

Dear Reader,

I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities).

🏆 Wall Street's Next MedTech Winner? BioStem (BSEM) Is Breaking Records 🚀 (ad)*
BioStem Technologies (OTC: BSEM) is emerging as one of the hottest MedTech stories of 2025. With record Q1 revenues of $72.5M — up 73% from last year — and six straight profitable quarters, this regenerative medicine company is firing on all cylinders. BioStem's BioREtain® platform is redefining chronic wound care with superior clinical results. National recognition for CEO Jason Matuszewski (EY Entrepreneur of the Year 2025) underscores strong leadership. Analysts are paying attention too — Zacks issued a $25.50 price target.
💡 Learn why BioStem's innovation could reshape a multi-billion-dollar market.

Symbol Company	Earning Date	EPS Surprise %
CSX	10/16	4.76%
BK	10/16	8.52%
ASML	10/15	2.23%
ASML	10/15	2.23%
SYF	10/15	28.83%
SYF	10/15	28.83%
BAC	10/15	12.77%
BAC	10/15	12.77%
BAC	10/15	12.77%
BAC	10/15	12.77%
PNC	10/15	7.41%
PNC	10/15	7.41%
MS	10/15	34.62%
MS	10/15	34.62%
DPZ	10/14	3.03%
Click Here to View Your Full Report

Before Market Open

After Market Close

🎯 Trade this between 9:30 and 10:45 am EST (ad)
Options Pro Reveals His #1 Retirement Income Trade If you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto trades, you'll want to see my new e-book, How To Master The Retirement Trade. It reveals a simple, time-based strategy that targets trades designed to play out in as little as 11 hours — no guesswork, no hype.
Claim your free copy of How To Master The Retirement Trade now.

BSEM: Leading the MedTech Charge with Record Revenue and Nasdaq Potential (ad)*
BioStem Technologies (OTC: BSEM) is quietly becoming one of the biggest success stories in regenerative medicine. The company just announced record Q1 revenue of $72.5M, up 73% YoY, and six consecutive quarters of profitability. BioStem's proprietary BioREtain® platform is revolutionizing chronic wound care, supported by a rapidly expanding patent portfolio. With CMS reimbursement approvals, major clinical trials, and a Nasdaq uplisting on the horizon, this could be one of 2025's top MedTech growth stories.
🔥 Don't miss your chance to see why BioStem could dominate wound care innovation.

How to use EPS Surprice in your Post-Earnings trading strategies:

Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on Ride-the-Wave Strategy to learn more about it.

Stock Trading - If you're a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company.

At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.

To your trading success,

Support Team

Daily Options Signals

PS: Daily Options Signals is morning newsletter, powered by StockEarnings proprietary technology.

URGENT: Trump's AI Policy Shift

Massive manufacturing reshoring is coming

FREE report just released → Get your copy before it's too late

(ad)* This message is a PAID ADVERTISEMENT for Banzai International, Inc (NASDAQ: BNZI) from Sideways Frequency. StockEarnings, Inc. has received a fixed fee of $6,000 from Sideways Frequency for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between October 17, 2025 and October 23, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Banzai International, Inc (NASDAQ: BNZI) or Sideways Frequency. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Banzai International, Inc (NASDAQ: BNZI) on Huge Alerts website for additional information about the relationship between Sideways Frequency and Banzai International, Inc (NASDAQ: BNZI).

Daily Options Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

💹 Your Post-Notable Earnings Report (Oct 17)

0 Response to "💹 Your Post-Notable Earnings Report (Oct 17)"

Post a Comment